Teprotumumab Reduces Extraocular Muscle and Orbital Fat Volume in Thyroid Eye Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease
Br J Ophthalmol 2022 Feb 01;106(2)165-171, AP Jain, N Gellada, S Ugradar, A Kumar, G Kahaly, R DouglasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.